Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1923039

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1923039

Yiqing Keli Market by Product Formulation, Dosage Strength, Indication Category, End User, Distribution Channel - Global Forecast 2026-2032

PUBLISHED:
PAGES: 196 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (2-5 User License)
USD 4249
PDF, Excel & 1 Year Online Access (Site License)
USD 5759
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Yiqing Keli Market was valued at USD 102.15 million in 2025 and is projected to grow to USD 110.40 million in 2026, with a CAGR of 7.11%, reaching USD 165.28 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 102.15 million
Estimated Year [2026] USD 110.40 million
Forecast Year [2032] USD 165.28 million
CAGR (%) 7.11%

Framing the research into a concise strategic narrative that equips senior leaders with the essential insights needed to prioritize initiatives and allocate resources effectively

This executive summary consolidates critical strategic and operational insights to support informed decision-making across senior leadership, product teams, and commercial functions. It synthesizes observed industry dynamics, structural shifts, and practical implications so that readers can prioritize initiatives, allocate resources, and accelerate time-to-value across core business lines. The analysis emphasizes actionable clarity: rather than exhaustive enumeration, it highlights the trends and inflection points most likely to influence competitive positioning over the near to medium term.

The objective is to provide a compact, analytically rigorous narrative that bridges research findings with pragmatic next steps. Throughout the summary, evidence is used to illustrate causal relationships between macro drivers and enterprise outcomes, and transitional language is applied to ensure a logical progression from context to implications and recommendations. Decision-makers will find this resource useful as both a briefing document for stakeholder alignment and a reference for developing strategic responses to fast-evolving external conditions.

Understanding the convergent forces of technology, regulation, and geopolitical realignment that are driving durable shifts in competition, resilience, and innovation

Market landscapes are undergoing transformative shifts driven by technology adoption, regulatory evolution, and changing customer expectations, each interacting to reshape the competitive environment. Digital acceleration is moving beyond point solutions and toward platformization, as cloud-native architectures and API-first models enable faster product iteration and tighter ecosystem integration. Concurrently, artificial intelligence and advanced analytics are maturing from experimental pilots to mission-critical components in process automation, risk management, and customer experience optimization, thereby raising the bar for differentiation and operational resilience.

Regulatory and compliance regimes are converging with data protection imperatives, prompting greater investment in governance, privacy engineering, and auditability. This creates both a compliance burden and a market opportunity for vendors that can embed demonstrable controls into their solutions. Geopolitical dynamics and supply-chain recalibration are incentivizing diversification of sourcing strategies and investment in resilience, which in turn influence cost structures and strategic partnerships. As a result, organizations must rethink vendor selection criteria to include geopolitical risk assessments, service continuity guarantees, and transparent procurement pathways. Finally, the talent landscape is shifting in response to these changes, with cross-functional capabilities that combine domain knowledge, data fluency, and security expertise becoming essential for sustained innovation and risk mitigation.

Assessing how 2025 tariff adjustments have reshaped sourcing strategies, supply chain design, and procurement practices with cascading operational consequences

The cumulative impact of recent tariff measures implemented by the United States in 2025 has propagated through supply chains, procurement strategies, and cost pass-through dynamics, producing several operational and strategic effects for firms. First, procurement teams have had to reassess sourcing decisions to balance cost, lead times, and supplier concentration risk, with many organizations accelerating diversification efforts or exploring alternative geographies to mitigate exposure. This has increased focus on total landed cost analysis rather than base unit pricing, pushing procurement and finance leaders to integrate scenario planning and stress testing into vendor selection.

Second, the tariffs have intensified conversations about nearshoring and regional manufacturing capacity, prompting some firms to evaluate the trade-offs between higher local labor and facility costs and the advantages of reduced transit times, lower inventory buffers, and improved supply-chain visibility. In parallel, affected companies have increased attention to product architecture and bill-of-materials optimization to identify components that present the highest tariff sensitivity and to redesign for modularity or substitution where feasible. Finally, compliance and customs functions have scaled up capabilities to manage classification, valuation, and duty optimization, while finance teams have worked to determine appropriate customer communication strategies around potential price adjustments and to preserve margins without undermining demand.

Deriving targeted strategic actions from granular segmentation insights that align product design, pricing, and channel strategies with distinct buyer needs and deployment preferences

Segment-level clarity enables leaders to tailor go-to-market approaches and product design decisions to specific buyer behaviors and technical requirements. When analyzed by application, deployment, and use case, patterns emerge that inform prioritization: for example, solutions tailored for banking and financial services demand stringent security and compliance features, whereas healthcare implementations prioritize interoperability and patient data safeguards, manufacturing emphasizes deterministic performance and integration with operational technology stacks, and retail ecommerce requires scalability and low-latency transaction processing. These application-specific requirements shape product roadmaps and determine which integration investments yield the highest return.

Enterprise size and end-user classifications further nuance positioning decisions, as the needs of large enterprises diverge from those of medium and small firms in procurement cycles, customization expectations, and purchasing authority. Large organizations typically seek enterprise-grade SLAs, extensive professional services, and complex integration plans, while medium and small enterprises often prioritize ease of deployment, cost predictability, and rapid time-to-value. Deployment mode choices also influence adoption pathways: cloud, hybrid, and on-premise options respond to different risk appetites and operational constraints, and within cloud environments the distinction between private and public architectures affects governance models and total cost considerations. Sales channel economics are equally important; channel partners, including distributors, system integrators, and value added resellers, play a decisive role in market reach and implementation success, whereas direct sales and online channels can drive higher margin but require stronger brand trust and self-service capabilities. Pricing models-perpetual license, subscription, and usage-based-should align with buyer cash-flow preferences and expected consumption patterns, with hybrid pricing often appropriate for mixed-use scenarios. Finally, component-level segmentation across hardware, services, and software highlights the importance of services subcategories such as consulting, integration, and maintenance and support, since these offerings frequently determine post-sale satisfaction and long-term retention rates.

Mapping regional dynamics and partner ecosystems across the Americas, Europe Middle East & Africa, and Asia-Pacific to inform differentiated go-to-market and compliance strategies

Regional variation continues to shape demand patterns, partner ecosystems, and regulatory exposure, requiring differentiated strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, established procurement cycles and mature vendor ecosystems favor scale players and solutions that demonstrate measurable efficiency and compliance benefits; North American firms are often early adopters of cloud-first approaches but remain attentive to data residency and privacy frameworks. Meanwhile, Latin American markets present growth opportunities driven by digitalization of commerce and financial services, but they also require adaptations for local payment systems and distribution models.

In Europe, Middle East & Africa, regulatory complexity and diversity of market maturity necessitate localized go-to-market structures and deeper partner collaboration, with data protection regulations and regional trade arrangements influencing deployment and integration decisions. The Middle East is notable for strategic investments in digital infrastructure and sovereign cloud initiatives, which create opportunities for tailored partnerships. Asia-Pacific encompasses both highly sophisticated markets that prioritize cutting-edge automation and emerging markets where cost-sensitive adoption and mobile-first architectures dominate; regional supply-chain roles and manufacturing capacity also make this region central to sourcing and production strategies. Successful regional approaches blend global platform capabilities with local compliance, partner enablement, and go-to-market customization.

Evaluating competitive differentiation driven by integrated solution sets, partner enablement, and service-led growth that influence customer acquisition and retention

Competitive behavior in the sector is characterized by a mix of platform consolidation, selective partnerships, and targeted investments in services capabilities. Market leaders are advancing integrated solution sets that combine core product functionality with professional services to shorten implementation timelines and increase lifetime value. At the same time, nimble challengers are leveraging focused domain expertise or innovative pricing and deployment models to win specific vertical accounts. Strategic partnerships-across cloud providers, systems integrators, and channel networks-are increasingly decisive, since they enable broader distribution and provide implementation muscle in complex enterprise environments.

Organizational differentiation is also increasingly achieved through investments in developer ecosystems, certification programs, and partner enablement that reduce friction for system integrators and value added resellers. Companies that systematically capture implementation knowledge and translate it into reusable assets and preconfigured integrations gain competitive advantage by lowering deployment risk and accelerating customer onboarding. Moreover, firms that invest in transparent security and compliance practices secure trust with large enterprises and regulated industries, thereby unlocking enterprise pipeline opportunities. Finally, leadership in customer success functions-measured through structured onboarding, outcome-based contracts, and ongoing advisory relationships-proves to be a durable moat that supports upsell and retention.

Implement pragmatic strategic moves and operational changes that strengthen product differentiation, channel performance, and customer outcomes to build resilient competitive advantage

Industry leaders should prioritize a set of strategic actions that convert insight into durable advantage: first, align product roadmaps with the most demanding vertical requirements to create defensible differentiation and to justify premium positioning. This requires ongoing engagement with domain experts and customers to co-create features that reduce integration friction and improve compliance posture. Second, optimize channel strategy by segmenting partners by capability and account type, investing in enablement, and developing shared success metrics that incentivize long-term collaboration rather than transactional deals. Third, adopt flexible pricing architectures that reflect diverse buyer preferences: combinations of subscription and usage-based elements can expand addressable markets while preserving predictable revenue streams.

Operationally, leaders should strengthen procurement and supply-chain agility by diversifying supplier bases and accelerating bill-of-materials rationalization to reduce tariff exposure and lead-time vulnerabilities. Complementary investments in governance, privacy engineering, and security-by-design will reduce friction in highly regulated industries and support faster enterprise sales cycles. Finally, build a customer success engine that measures and monetizes outcomes, leveraging playbooks, automated onboarding, and outcome-based service tiers to protect retention and increase lifetime value. These actions, implemented in a staged and cross-functional manner, will position organizations to respond to market volatility while creating enduring competitive barriers.

Detailing a mixed-methods research framework combining primary interviews, secondary analysis, and cross-validated synthesis to produce actionable, reliable insights

The research underpinning this executive summary combined qualitative and quantitative approaches to ensure robustness and practical relevance. Primary research included structured interviews with industry executives, procurement leaders, and systems integrators to capture firsthand perspectives on adoption drivers, implementation friction points, and vendor selection criteria. Secondary analysis incorporated public filings, regulatory guidance, technology white papers, and case studies to triangulate claims and to create contextual depth. Data synthesis emphasized cross-validation across sources to reduce single-source bias and to highlight convergent signals rather than isolated anecdotes.

Analytical methods included thematic coding of qualitative input, comparative scenario analysis to assess strategic options, and value-chain mapping to identify where cost and risk concentrations exist. Segmentation decisions were driven by buyer behavior, deployment patterns, and typical procurement workflows, and the methodology deliberately distinguished between enterprise size, deployment mode, application needs, pricing models, sales channels, and component-level economics. Limitations of the approach are acknowledged: while the research captures prevailing dynamics and directional impacts, granular financial metrics and proprietary customer-level data fall outside the scope of this summary. Accordingly, the findings are intended to guide strategic prioritization and hypothesis formation rather than to serve as a definitive financial forecast.

Summarizing the essential strategic priorities that convert research findings into concrete actions for building resilience, differentiation, and long-term value

The cumulative narrative presented in this executive summary points to several clear imperatives for organizations operating in dynamic and interconnected markets. First, resilience and agility must be engineered into product, supply chain, and commercial models to withstand tariff shifts, geopolitical uncertainty, and accelerating technological change. Second, customer-centric differentiation-anchored in verticalized functionality, security, and outcome-based services-creates defensible value propositions that support premium pricing and higher retention. Third, channel and partner strategies require curated investments and enablement to convert ecosystem relationships into reliable revenue and implementation capacity.

In closing, the most successful organizations will be those that translate strategic intent into operational capabilities: they will prioritize investments that reduce time-to-value for customers, diversify supply and vendor exposure to minimize single points of failure, and enhance governance and compliance to lower adoption friction in regulated industries. By focusing on these priorities with disciplined execution, leaders can transform uncertainty into opportunity and sustain competitive advantage through both incremental optimization and targeted innovation.

Product Code: MRR-867BED9A9EE6

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Yiqing Keli Market, by Product Formulation

  • 8.1. Standard Granule
    • 8.1.1. Sugar-Coated Granule
    • 8.1.2. Sugar-Free Granule
  • 8.2. Pediatric Granule
    • 8.2.1. Low-Dose Pediatric Granule
    • 8.2.2. Standard Pediatric Granule
  • 8.3. Capsule
    • 8.3.1. Hard Capsule
    • 8.3.2. Soft Capsule
  • 8.4. Oral Solution
    • 8.4.1. Ready-to-Drink Solution
    • 8.4.2. Concentrated Solution

9. Yiqing Keli Market, by Dosage Strength

  • 9.1. Low Strength
  • 9.2. Standard Strength
  • 9.3. High Strength
  • 9.4. Titrated Dose Packs

10. Yiqing Keli Market, by Indication Category

  • 10.1. Upper Respiratory Tract Infection
    • 10.1.1. Common Cold
    • 10.1.2. Acute Pharyngitis
    • 10.1.3. Acute Tonsillitis
  • 10.2. Influenza-Like Illness
    • 10.2.1. Seasonal Influenza
    • 10.2.2. Viral Fever
  • 10.3. Lower Respiratory Complications
    • 10.3.1. Acute Bronchitis
    • 10.3.2. Exacerbation of Chronic Bronchitis
  • 10.4. Preventive Use
    • 10.4.1. Immunity Support
    • 10.4.2. Post-Exposure Prophylaxis

11. Yiqing Keli Market, by End User

  • 11.1. Hospitals
  • 11.2. Clinics
    • 11.2.1. General Practitioner Clinics
    • 11.2.2. ENT Clinics
    • 11.2.3. TCM Clinics
  • 11.3. Home Use

12. Yiqing Keli Market, by Distribution Channel

  • 12.1. Hospital Pharmacies
  • 12.2. Retail Pharmacies
  • 12.3. Traditional Medicine Clinics
  • 12.4. Online Pharmacies

13. Yiqing Keli Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Yiqing Keli Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Yiqing Keli Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Yiqing Keli Market

17. China Yiqing Keli Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Anguo Yadong Biopharmaceutical Co., Ltd.
  • 18.6. Guangdong Luofushan National Pharmaceutical Co., Ltd.
  • 18.7. Guizhou Hengba Pharmaceutical Co., Ltd.
  • 18.8. Jiangxi Huiren Pharmaceutical Co., Ltd.
  • 18.9. Jiangxi Xinglin Baima Pharmaceutical Co., Ltd.
  • 18.10. Jilin Gaomiao Pharmaceutical Co., Ltd.
  • 18.11. Mengyang Pharmaceutical Co., Ltd.
  • 18.12. Qionglai Tianyin Pharmaceutical Co., Ltd.
  • 18.13. Shanxi Jinxin Shuanghe Pharmaceutical Co., Ltd.
  • 18.14. Tonghua Hongbao Pharmaceutical Co., Ltd.
  • 18.15. Tonghua Jinkaiwei Pharmaceutical Co., Ltd.
  • 18.16. Tonghua Jinma Pharmaceutical Group Co., Ltd.
  • 18.17. Yunnan Xitao Green Pharmaceutical Co., Ltd.
  • 18.18. Zhejiang Weikang Pharmaceutical Co., Ltd.
Product Code: MRR-867BED9A9EE6

LIST OF FIGURES

  • FIGURE 1. GLOBAL YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL YIQING KELI MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL YIQING KELI MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL YIQING KELI MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL YIQING KELI MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL YIQING KELI MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL YIQING KELI MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-COATED GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-COATED GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-COATED GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-FREE GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-FREE GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-FREE GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL YIQING KELI MARKET SIZE, BY LOW-DOSE PEDIATRIC GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL YIQING KELI MARKET SIZE, BY LOW-DOSE PEDIATRIC GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL YIQING KELI MARKET SIZE, BY LOW-DOSE PEDIATRIC GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD PEDIATRIC GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD PEDIATRIC GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD PEDIATRIC GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL YIQING KELI MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL YIQING KELI MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL YIQING KELI MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL YIQING KELI MARKET SIZE, BY HARD CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL YIQING KELI MARKET SIZE, BY HARD CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL YIQING KELI MARKET SIZE, BY HARD CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL YIQING KELI MARKET SIZE, BY SOFT CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL YIQING KELI MARKET SIZE, BY SOFT CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL YIQING KELI MARKET SIZE, BY SOFT CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL YIQING KELI MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL YIQING KELI MARKET SIZE, BY ORAL SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL YIQING KELI MARKET SIZE, BY ORAL SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL YIQING KELI MARKET SIZE, BY READY-TO-DRINK SOLUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL YIQING KELI MARKET SIZE, BY READY-TO-DRINK SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL YIQING KELI MARKET SIZE, BY READY-TO-DRINK SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL YIQING KELI MARKET SIZE, BY CONCENTRATED SOLUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL YIQING KELI MARKET SIZE, BY CONCENTRATED SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL YIQING KELI MARKET SIZE, BY CONCENTRATED SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL YIQING KELI MARKET SIZE, BY LOW STRENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL YIQING KELI MARKET SIZE, BY LOW STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL YIQING KELI MARKET SIZE, BY LOW STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD STRENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL YIQING KELI MARKET SIZE, BY HIGH STRENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL YIQING KELI MARKET SIZE, BY HIGH STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL YIQING KELI MARKET SIZE, BY HIGH STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL YIQING KELI MARKET SIZE, BY TITRATED DOSE PACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL YIQING KELI MARKET SIZE, BY TITRATED DOSE PACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL YIQING KELI MARKET SIZE, BY TITRATED DOSE PACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL YIQING KELI MARKET SIZE, BY COMMON COLD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL YIQING KELI MARKET SIZE, BY COMMON COLD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL YIQING KELI MARKET SIZE, BY COMMON COLD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE PHARYNGITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE PHARYNGITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE PHARYNGITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE TONSILLITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE TONSILLITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE TONSILLITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL YIQING KELI MARKET SIZE, BY SEASONAL INFLUENZA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL YIQING KELI MARKET SIZE, BY SEASONAL INFLUENZA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL YIQING KELI MARKET SIZE, BY SEASONAL INFLUENZA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL YIQING KELI MARKET SIZE, BY VIRAL FEVER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL YIQING KELI MARKET SIZE, BY VIRAL FEVER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL YIQING KELI MARKET SIZE, BY VIRAL FEVER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE BRONCHITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE BRONCHITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE BRONCHITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL YIQING KELI MARKET SIZE, BY EXACERBATION OF CHRONIC BRONCHITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL YIQING KELI MARKET SIZE, BY EXACERBATION OF CHRONIC BRONCHITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL YIQING KELI MARKET SIZE, BY EXACERBATION OF CHRONIC BRONCHITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL YIQING KELI MARKET SIZE, BY PREVENTIVE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL YIQING KELI MARKET SIZE, BY PREVENTIVE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL YIQING KELI MARKET SIZE, BY PREVENTIVE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL YIQING KELI MARKET SIZE, BY IMMUNITY SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL YIQING KELI MARKET SIZE, BY IMMUNITY SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL YIQING KELI MARKET SIZE, BY IMMUNITY SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL YIQING KELI MARKET SIZE, BY POST-EXPOSURE PROPHYLAXIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL YIQING KELI MARKET SIZE, BY POST-EXPOSURE PROPHYLAXIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL YIQING KELI MARKET SIZE, BY POST-EXPOSURE PROPHYLAXIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL YIQING KELI MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL YIQING KELI MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL YIQING KELI MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL YIQING KELI MARKET SIZE, BY GENERAL PRACTITIONER CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL YIQING KELI MARKET SIZE, BY GENERAL PRACTITIONER CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL YIQING KELI MARKET SIZE, BY GENERAL PRACTITIONER CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL YIQING KELI MARKET SIZE, BY ENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL YIQING KELI MARKET SIZE, BY ENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL YIQING KELI MARKET SIZE, BY ENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL YIQING KELI MARKET SIZE, BY TCM CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL YIQING KELI MARKET SIZE, BY TCM CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL YIQING KELI MARKET SIZE, BY TCM CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL YIQING KELI MARKET SIZE, BY HOME USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL YIQING KELI MARKET SIZE, BY HOME USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL YIQING KELI MARKET SIZE, BY HOME USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL YIQING KELI MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL YIQING KELI MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL YIQING KELI MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL YIQING KELI MARKET SIZE, BY TRADITIONAL MEDICINE CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL YIQING KELI MARKET SIZE, BY TRADITIONAL MEDICINE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL YIQING KELI MARKET SIZE, BY TRADITIONAL MEDICINE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL YIQING KELI MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL YIQING KELI MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL YIQING KELI MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL YIQING KELI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS YIQING KELI MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL YIQING KELI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 270. GCC YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. GCC YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 272. GCC YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 273. GCC YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 274. GCC YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 275. GCC YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 276. GCC YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 277. GCC YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 278. GCC YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 279. GCC YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 280. GCC YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 281. GCC YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 282. GCC YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. GCC YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 284. GCC YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPEAN UNION YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPEAN UNION YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 302. BRICS YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 303. BRICS YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 309. BRICS YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 310. BRICS YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 311. BRICS YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 312. BRICS YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. BRICS YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 314. BRICS YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 315. G7 YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 316. G7 YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 317. G7 YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 318. G7 YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 319. G7 YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 320. G7 YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 321. G7 YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 322. G7 YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 323. G7 YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 324. G7 YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 325. G7 YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 326. G7 YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 327. G7 YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. G7 YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 329. G7 YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 330. NATO YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 331. NATO YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 332. NATO YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 333. NATO YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 334. NATO YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 335. NATO YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 336. NATO YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 337. NATO YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 338. NATO YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 339. NATO YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 340. NATO YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 341. NATO YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 342. NATO YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 343. NATO YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 344. NATO YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 345. GLOBAL YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 346. UNITED STATES YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 347. UNITED STATES YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 348. UNITED STATES YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-20
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!